Our muti‐omics analyses of ATPCRs across large‐scale cancer specimens identified potential therapeutic targets and our experimental studies revealed a novel CHD7‐AK4‐AMPK‐p53 axis that plays an oncogenic role in colorectal cancer. Here, TP53 is linked to colorectal cancer.